These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 25184834)

  • 1. Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome.
    Theodorou V; Ait Belgnaoui A; Agostini S; Eutamene H
    Gut Microbes; 2014; 5(3):430-6. PubMed ID: 25184834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.
    Lee KN; Lee OY
    World J Gastroenterol; 2014 Jul; 20(27):8886-97. PubMed ID: 25083061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics and irritable bowel syndrome.
    Dai C; Zheng CQ; Jiang M; Ma XY; Jiang LJ
    World J Gastroenterol; 2013 Sep; 19(36):5973-80. PubMed ID: 24106397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions.
    Hyland NP; Quigley EM; Brint E
    World J Gastroenterol; 2014 Jul; 20(27):8859-66. PubMed ID: 25083059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Irritable Bowel Syndrome, Emotion Regulation, and Gut Microbiota].
    Fukudo S
    Brain Nerve; 2016 Jun; 68(6):607-15. PubMed ID: 27279158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome.
    Singh P; Lembo A
    Gastroenterol Clin North Am; 2021 Sep; 50(3):523-545. PubMed ID: 34304786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets.
    Dupont HL
    Aliment Pharmacol Ther; 2014 May; 39(10):1033-42. PubMed ID: 24665829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut microbiome and irritable bowel syndrome: State of art review.
    Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
    Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain.
    Aziz MNM; Kumar J; Muhammad Nawawi KN; Raja Ali RA; Mokhtar NM
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the gut microbiota for the treatment of irritable bowel syndrome.
    Herndon CC; Wang YP; Lu CL
    Kaohsiung J Med Sci; 2020 Mar; 36(3):160-170. PubMed ID: 31782606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irritable bowel syndrome: a gut microbiota-related disorder?
    Bhattarai Y; Muniz Pedrogo DA; Kashyap PC
    Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G52-G62. PubMed ID: 27881403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the ties between irritable bowel syndrome and intestinal microbiota.
    Hong SN; Rhee PL
    World J Gastroenterol; 2014 Mar; 20(10):2470-81. PubMed ID: 24627584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
    Mamieva Z; Poluektova E; Svistushkin V; Sobolev V; Shifrin O; Guarner F; Ivashkin V
    World J Gastroenterol; 2022 Mar; 28(12):1204-1219. PubMed ID: 35431513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.
    Botschuijver S; Roeselers G; Levin E; Jonkers DM; Welting O; Heinsbroek SEM; de Weerd HH; Boekhout T; Fornai M; Masclee AA; Schuren FHJ; de Jonge WJ; Seppen J; van den Wijngaard RM
    Gastroenterology; 2017 Oct; 153(4):1026-1039. PubMed ID: 28624575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome.
    Simon E; Călinoiu LF; Mitrea L; Vodnar DC
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34203002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota and therapeutic approaches for dysbiosis in irritable bowel syndrome: recent developments and future perspectives.
    Dale HF; Lied GA
    Turk J Med Sci; 2020 Nov; 50(SI-2):1632-1641. PubMed ID: 32222124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irritable bowel syndrome, gut microbiota and probiotics.
    Lee BJ; Bak YT
    J Neurogastroenterol Motil; 2011 Jul; 17(3):252-66. PubMed ID: 21860817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-specific insights into the irritable bowel syndrome pathophysiology. Focus on gut dysbiosis and permeability.
    JohnBritto JS; Di Ciaula A; Noto A; Cassano V; Sciacqua A; Khalil M; Portincasa P; Bonfrate L
    Eur J Intern Med; 2024 Jul; 125():10-18. PubMed ID: 38467533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.